Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nutex Health (NUTX) Current Leases (2019 - 2025)

Nutex Health's Current Leases history spans 7 years, with the latest figure at $2.2 million for Q4 2025.

  • For Q4 2025, Current Leases rose 3.46% year-over-year to $2.2 million; the TTM value through Dec 2025 reached $2.2 million, up 3.46%, while the annual FY2025 figure was $2.2 million, 3.46% up from the prior year.
  • Current Leases for Q4 2025 was $2.2 million at Nutex Health, down from $7.1 million in the prior quarter.
  • Across five years, Current Leases topped out at $8.0 million in Q1 2025 and bottomed at $44305.0 in Q2 2021.
  • The 5-year median for Current Leases is $1.7 million (2022), against an average of $2.5 million.
  • The largest annual shift saw Current Leases surged 8520.29% in 2023 before it plummeted 61.47% in 2024.
  • A 5-year view of Current Leases shows it stood at $1.5 million in 2021, then grew by 17.25% to $1.7 million in 2022, then fell by 7.22% to $1.6 million in 2023, then skyrocketed by 31.65% to $2.1 million in 2024, then increased by 3.46% to $2.2 million in 2025.
  • Per Business Quant, the three most recent readings for NUTX's Current Leases are $2.2 million (Q4 2025), $7.1 million (Q3 2025), and $2.1 million (Q2 2025).